Explainer

What Is an Anxiety Pen? Types, Ingredients and the Evidence

An anxiety pen is usually a nicotine-free vape sold for calm. None is FDA-approved, and 25.9% of people aged 13 to 40 surveyed in 2021 had tried such a vape.

Mental Health Stats Research Team 7 min read

Key Takeaways

  • An anxiety pen is not a medical device or drug: FDA says no vaping product is approved to prevent or treat any health condition[1].0 approved[1]
  • In a 2021 U.S. survey of people aged 13 to 40, 25.9% had ever used a nicotine-free e-cigarette, the product category most anxiety pens belong to[2].25.9%[2]
  • CBD, the best-studied anxiety-pen ingredient, reduced anxiety in a 2024 meta-analysis of 8 studies, but the 316-person evidence base was small and the confidence interval wide[3].8 studies[3]
  • In a 2017 JAMA analysis, 87.5% of CBD vaping liquids bought online were mislabeled for CBD content[4].87.5%[4]
  • In an FDA-run 2025 trial, 5.6% of healthy adults taking daily oral CBD at consumer-level doses developed liver enzyme elevations above three times normal[5].5.6%[5]

What Is an Anxiety Pen?

An anxiety pen is a pen-shaped product sold to ease stress or anxiety, most often a nicotine-free vape that heats a flavored liquid containing botanicals, vitamins, melatonin or CBD. The label is a marketing term, not a clinical one: FDA states that no vaping product is approved to prevent or treat any health condition[1].

The same name also covers no-heat essential-oil inhalers and mechanical fidget pens with no active ingredient at all. What a buyer gets depends on which of these four products sits behind the label.

Figures on how many people live with anxiety disorders are on the anxiety statistics page.

Anxiety pen

An informal retail name for a handheld, pen-shaped product marketed for calm or stress relief. Most are battery-powered vaporizers (sometimes sold as "personal diffusers" or "wellness vapes") that aerosolize a liquid for inhalation; others are unheated aromatherapy inhalers or fidget pens. FDA has issued warning letters to sellers of vitamin and essential-oil vaping products marketed with unproven health claims[1].

Related Terms

personal diffuser
nicotine-free vape
wellness vape
CBD vape pen
aromatherapy inhaler
fidget pen

Source: U.S. Food and Drug Administration

Four Products Sold as Anxiety Pens

TypeHow it worksTypical contentsEvidence for the product itself
Botanical or vitamin vape ("diffuser")Heats a liquid into an inhaled aerosolFlavorings, essential oils, vitamin B12, melatonin, caffeineNo approved health claims
CBD vape penHeats a CBD oil or liquid into an aerosolCannabidiol, carrier liquid, sometimes trace THCTrials test CBD, not pens
Aromatherapy inhalerUnheated wick sniffed through the noseEssential oils such as lavenderTrials test aromatherapy, not pens
Fidget penClicking, spinning or squeezing partsNoneNo active ingredient

Product types marketed under the anxiety pen label. Contents reflect ingredients U.S. users reported in nicotine-free e-cigarettes in 2021[2] and product types named in FDA warning letters[1].

1FDA states that no vaping product is approved to prevent or treat any health condition[1].

Sources

  • •Gaiha et al., JAMA Network Open, 2022
  • •U.S. Food and Drug Administration, 2021

What Is Inside an Anxiety Pen?

Researchers who surveyed 6,131 U.S. residents aged 13 to 40 in 2021 found that people who used nicotine-free e-cigarettes most often reported THC (36.9%), CBD (33.7%), melatonin (27.5%), caffeine (26.9%) and essential oils (22.9%) in their devices[2].

The active ingredient is only part of the liquid. A German chemical analysis of 54 e-liquids found that propylene glycol averaged 57 g per 100 g and glycerol 37 g per 100 g, the solvents that carry flavor and active ingredients into the aerosol[6].

Testing has also turned up ingredients that were not on the label. A 2024 laboratory study of three commercial melatonin vapes found potential contaminants, including pharmaceuticals and industrial chemicals, and melatonin aerosol produced an immunosuppressive gene-expression pattern in human airway cells[7].

Ingredients Reported in Nicotine-Free Vapes

IngredientShare of ever-users
THC36.9%
CBD33.7%
Melatonin27.5%
Caffeine26.9%
Essential oils22.9%

Ingredients reported by 1,590 U.S. residents aged 13 to 40 who had ever used a nicotine-free e-cigarette, online survey, November to December 2021[2].

1Convenience sample with quota sampling by age; respondents could report more than one ingredient[2], so shares do not sum to 100%.

Sources

  • •Gaiha et al., JAMA Network Open, 2022
How to read the evidence: The studies below tested ingredients such as CBD and lavender, not commercial anxiety pens. FDA lists how vaping changes CBD intake as one of the open questions about the compound[8], so the dose a pen delivers is generally unknown.

Do Anxiety Pens Work?

There is research on some anxiety-pen ingredients, but it does not show that the pens themselves work. The evidence is strongest for CBD and lavender, and both bodies of research have clear limits.

CBD

A 2024 meta-analysis pooled 8 studies with 316 participants and found a large average reduction in anxiety with CBD (Hedges' g = -0.92)[3]. The 95% confidence interval ran from -1.80 to -0.04, close to no effect at one end, and the authors urged caution because of the small clinical sample[3].

Product quality adds a second layer of uncertainty. When researchers tested 84 CBD products bought online in 2017, only 30.95% were accurately labeled, and 87.5% of vaporization liquids were mislabeled, the worst rate of any product type[4].

Lavender and other essential oils

A 2019 meta-analysis of 22 randomized trials found that lavender aromatherapy reduced self-rated anxiety (Hedges' g = -0.65)[9]. The trials used lavender oil in several forms, and the authors called for studies of better methodological quality[9].

A pen that heats lavender oil into an aerosol is a different exposure from smelling the oil, and FDA has warned that inhaled wellness products can cause coughing and airway tightening[1]. The evidence for other botanicals and supplements is reviewed in supplements for anxiety.

The ritual itself

Using any inhaler involves a slow, deliberate breath. Slow breathing has been tested on its own as an anxiety technique, and that evidence is covered in deep breathing for anxiety.

Fidget pens contain nothing to inhale, so any effect is behavioral. The closest research, on handheld squeeze tools, is summarized in squeeze ball for anxiety.

Vaping products FDA has approved to prevent or treat any health condition
0

Anxiety pens that make calming or mental-health claims are sold without FDA review of whether they work or are safe to inhale. FDA has issued warning letters to firms selling vitamin and essential-oil vaping products with unproven claims.

"Currently, no vaping products are approved by the FDA to prevent or treat any health conditions or diseases."

U.S. Food and Drug Administration(2021) View Source

Are Anxiety Pens Safe?

Long-term safety data for anxiety pens do not exist, and federal agencies have flagged several specific risks. FDA warns that inhaled wellness products may trigger severe coughing and airway tightening, and that there is no way to know whether they contain impurities that could cause lasting damage[1].

Lung and airway risks

In a 2022 warning letter about essential-oil inhalation products, FDA wrote that ingredients or impurities in oral inhalation products may trigger laryngospasm or bronchospasm and may be toxic to airway tissue[10]. Essential oils that are safe to smell are not necessarily safe to inhale as a heated aerosol.

As of February 2020, CDC had recorded 2,807 hospitalized cases or deaths from e-cigarette or vaping product use-associated lung injury (EVALI), including 68 confirmed deaths, with THC-containing products and the additive vitamin E acetate strongly linked to the outbreak[11].

CDC and FDA also advise against adding any substance to a vaping product that the manufacturer did not intend[11].

CBD-specific risks

FDA states that CBD can cause liver injury, can change how other medicines work, and raises the risk of sedation when combined with alcohol or drugs used for anxiety, panic or sleep[8]. That last interaction matters for people already taking anxiety medication such as benzodiazepines.

In a 2025 FDA-run randomized trial, 8 of the healthy adults taking oral CBD at 250 to 550 mg a day for 28 days, or 5.6%, developed ALT liver enzyme levels above three times the upper limit of normal, compared with none on placebo[5]. Enzyme levels returned to normal within 1 to 2 weeks after stopping, and the trial did not test vaped CBD[5].

Do Anxiety Pens Contain Nicotine, and Who Uses Them?

Most anxiety pens are sold as nicotine-free, but labels are not always accurate. In a 2014 German analysis, only 18 of 23 e-liquids labeled nicotine-free were confirmed to contain no nicotine[6]; that study is dated and tested German products.

Use of nicotine-free vapes is common among young people. In the 2021 survey of U.S. residents aged 13 to 40, 25.9% had ever used a nicotine-free e-cigarette and 16.7% had used one in the past 30 days[2].

Among 13- to 17-year-olds in that survey, 13.9% had ever used one, and 18.8% of all respondents used nicotine-free and nicotine e-cigarettes together[2]. The study used a convenience sample, so the figures describe its respondents rather than the national population[2].

How Anxiety Pens Compare With Established Anxiety Treatment

For diagnosed anxiety disorders, the treatments with the strongest evidence are psychotherapy and medication. NIMH describes cognitive behavioral therapy as the "gold standard" psychotherapy for generalized anxiety disorder and lists SSRIs, SNRIs, buspirone and benzodiazepines among effective medications[12].

NIMH also notes that healthy lifestyle changes and stress-management techniques can reduce symptoms when paired with standard care but cannot replace treatment on their own[12]. An anxiety pen sits outside even that category, since its ingredients and doses are not standardized.

Comparisons of the main options are in therapy for anxiety and anxiety medication. For fast, non-drug techniques that have been tested, see how to reduce anxiety immediately.

Frequently Asked Questions

Sources & References

  1. U.S. Food and Drug Administration. FDA Takes Action to Protect Consumers From Vaping Products With Unproven Health Claims. Published 2021. Accessed October 2026. https://www.fda.gov/consumers/health-fraud-scams/fda-takes-action-protect-consumers-vaping-products-unproven-health-claims [Link]
  2. Gaiha SM, Lin C, Lempert LK, Halpern-Felsher B. Use Patterns, Flavors, Brands, and Ingredients of Nonnicotine e-Cigarettes Among Adolescents, Young Adults, and Adults in the United States. JAMA Network Open. Published 2022. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/35612852/ [Link]
  3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic Potential of Cannabidiol (CBD) in Anxiety Disorders: A Systematic Review and Meta-Analysis. Psychiatry Research. Published 2024. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/38924898/ [Link]
  4. Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA. Published 2017. Accessed October 2026. https://jamanetwork.com/journals/jama/fullarticle/2661569 [Link]
  5. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. CDER Investigators Address the Safety of CBD in a Randomized Trial. U.S. Food and Drug Administration. Published 2025. Accessed October 2026. https://www.fda.gov/drugs/regulatory-science-action/cder-investigators-address-safety-cbd-randomized-trial [Link]
  6. Hahn J, Monakhova YB, Hengen J, et al. Electronic Cigarettes: Overview of Chemical Composition and Exposure Estimation. Tobacco Induced Diseases. Published 2014. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/25620905/ [Link]
  7. Schichlein KD, Kim HH, Love CA, et al. Melatonin Vapes Contain Potential Contaminants and Alter the Human Bronchial Epithelial Transcriptome. Chemical Research in Toxicology. Published 2024. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/39528387/ [Link]
  8. U.S. Food and Drug Administration. What You Need to Know (And What We're Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD. Published 2020. Accessed October 2026. https://www.fda.gov/consumers/consumer-updates/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis [Link]
  9. Kang HJ, Nam ES, Lee Y, Kim M. How Strong Is the Evidence for the Anxiolytic Efficacy of Lavender? Systematic Review and Meta-Analysis of Randomized Controlled Trials. Asian Nursing Research. Published 2019. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/31743795/ [Link]
  10. U.S. Food and Drug Administration. Warning Letter: MONQ, LLC (MARCS-CMS 613570). Published 2022. Accessed October 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/monq-llc-613570-06302022 [Link]
  11. Centers for Disease Control and Prevention. Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products. Published 2021. Accessed October 2026. https://archive.cdc.gov/www_cdc_gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html [Link]
  12. National Institute of Mental Health. Generalized Anxiety Disorder: What You Need to Know. Published 2025. Accessed October 2026. https://www.nimh.nih.gov/health/publications/generalized-anxiety-disorder-gad [Link]

Related Statistics